Ann: Suspension from Official Quotation, page-13

Looking back on the ASX query reply as follows, the two statements following each other do seem to be quite contradictory.

In making this determination, the Directors have considered the Company’s forecasted growth in commercial sales, continued reduction in expenses and capital infusion. In particular:

• The Directors note that there is sufficient working capital to support committed research and commercialization activities over the next 12 months.

• The Directors are of the opinion that sufficient additional funding can be secured in the coming period and are reviewing all potential alternatives of funding the business.